C-erbB2/Her2/neu oncoprotein IVD, control - UK MHRA Medical Device Registration

C-erbB2/Her2/neu oncoprotein IVD, control is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 136231. The device is manufactured by Ventana Medical Systems, Inc. from United States, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Roche Diagnostics Limited.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

MHRA Registered

In Vitro Diagnostic Device

🇬🇧

C-erbB2/Her2/neu oncoprotein IVD, control

MHRA Device ID: 136231•Ref: 136231

Device Type

In Vitro Diagnostic Device

Devices

C-erbB2/Her2/neu oncoprotein IVD, control

Type

Class C

Date Registered

Sep 15, 2024

Last Updated

Jul 10, 2024

Manufacturer Information

Name

Ventana Medical Systems, Inc.

Address

1910 E Innovation Park Drive

Tucson, United States

Created Date

Mar 26, 2021

Authorized Representative

Name

Roche Diagnostics Limited

Relationship Type

UK Responsible Person

Address

Roche Diagnostics Limited Charles Avenue

Burgess Hill, West Sussex, United Kingdom

Postcode: RH15 9RY

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Other Products from Ventana Medical Systems, Inc. (10)

Other Products from Same Authorized Representative (10)

C-erbB2/Her2/neu oncoprotein IVD, control - UK MHRA Medical Device Registration

Device Type

Devices

Type

Date Registered

Last Updated

Name

Address

Created Date

Name

Relationship Type

Address

DJ Fang

Legionella pneumophila antigen IVD, kit, rapid ICT, clinical

Clostridium difficile antigen IVD, antibody

Streptococcus pneumoniae antigen IVD, kit, rapid ICT, clinical

Helicobacter pylori antigen IVD, kit, rapid ICT, clinical

Epstein-Barr virus (EBV) heterophile antibody IVD, kit, rapid ICT, clinical

Dengue virus antigen/antibody IVD, kit, rapid ICT, clinical

Respiratory syncytial virus (RSV) antigen IVD, kit, rapid ICT, clinical

SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing

Trichomonas vaginalis antigen IVD, kit, rapid ICT, clinical

Total cortisol IVD, reagent

Ki67 antigen IVD, antibody

Insulinoma-associated protein 1 (INSM1) IVD, antibody

Nucleic acid hybridization detection IVD, probe

p504s protein IVD, antibody

p53 tumour protein IVD, antibody

Phosphatase and tensin homolog (PTEN) protein IVD, antibody

Progesterone receptor IVD, antibody

Postmeiotic segregation increased 2 (PMS2) IVD, antibody

Programmed death-ligand 1 (PD-L1) IVD, antibody

Nucleic acid hybridization detection IVD, reagent

Cystatin C IVD, kit, nephelometry/turbidimetry

Cytomegalovirus (CMV) immunoglobulin M (IgM) antibody IVD, kit, chemiluminescent immunoassay

Cyclosporin A/cyclosporine therapeutic drug monitoring IVD, calibrator

Cystatin C IVD, control

Cytology specimen container IVD, transport buffer

Cytomegalovirus (CMV) immunoglobulin G (IgG) antibody IVD, kit, chemiluminescent immunoassay

Creatine?kinase?myocardial?isoenzyme (CKMB) IVD, kit, chemiluminescent immunoassay

Creatinine IVD, kit, enzyme spectrophotometry

Cyclosporin A/cyclosporine?therapeutic drug monitoring IVD, kit, chemiluminescent immunoassay

Cytomegalovirus (CMV) nucleic acid IVD, control